ANNUALIZED EXACERBATION RATE IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS BY PRESPECIFIED SUBGROUPS IN THE PH3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED ASPEN TRIAL

Authors
Category Primary study
JournalChest
Year 2024
This article has no abstract
Epistemonikos ID: 432bb3948aa37ce03ab728b03928983af0f012c7
First added on: Feb 19, 2025